Keyphrases
Targeted Cancer Therapy
100%
Combination Treatment
100%
Effective Combination
100%
Forkhead Box M1 (FOXM1)
100%
Breast Cancer Inhibition
100%
ER-positive
25%
Caspase 3/7 Activity
25%
Gene Expression
12%
Cell Viability
12%
Cancer Hallmarks
12%
Apoptosis Induction
12%
Breast Cancer
12%
Cell-to-cell
12%
Enhanced Efficacy
12%
Cell Cycle Progression
12%
Breast
12%
Changes in Gene Expression
12%
Apoptosis
12%
Dose Reduction
12%
Cancer Therapy
12%
Small Molecule Inhibitors
12%
All Cancer
12%
Treatment Options
12%
Protease Inhibitors
12%
Breast Cancer Treatment
12%
G2-M Cell Cycle Arrest
12%
Oncogenic Transcription Factors
12%
Antiproliferative Activity
12%
Antagonistic Interactions
12%
Targeted Treatment
12%
Breast Cancer Recurrence
12%
Triple-negative Breast Cancer
12%
Triple-negative Breast Cancer Cells
12%
Additive Interaction
12%
Breast Cancer Subtypes
12%
Hormone Receptor-positive Breast Cancer
12%
Pharmacological Class
12%
Proliferation Inhibition
12%
CDK4/6 Inhibitor Palbociclib
12%
Breast Cancer Receptors
12%
Zero-interaction
12%
Combination Index
12%
Ribociclib
12%
Synergistic Inhibition
12%
Abemaciclib
12%
Synergistic Additives
12%
Synergy Index
12%
Biochemistry, Genetics and Molecular Biology
Gene Expression
100%
Caspase 3
100%
Programmed Cell Death
100%
Transcription Factors
50%
Small Molecule
50%
Hormone Receptor
50%
Cell Viability
50%
Carcinogenesis
50%
Cell Cycle Progression
50%
Cancer Cell
50%
Cell Cycle Arrest
50%
Proteasome Inhibitor
50%
Cell Cycle Checkpoint
50%
Drug Dose Reduction
50%
Drug Therapy
50%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Breast Cancer
100%
Cancer Inhibition
100%
Caspase 3
33%
Triple Negative Breast Cancer
33%
Cell Viability
16%
Carcinogenesis
16%
Transcription Factors
16%
Pharmacotherapy
16%
Hormone Receptor
16%
Proteasome Inhibitor
16%
Palbociclib
16%
Ribociclib
16%
Abemaciclib
16%